Join to view full profile
915 Gessner RdSuite 720Houston, TX 77024
Phone+1 713-830-9100
Dr. Skolnick is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Michael Reese Hospital and Medical CenterResidency, Urology, 1968 - 1972- Advocate Health Care/Advocate Lutheran General HospitalInternship, Internal Medicine, 1965 - 1966
Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 1965
Certifications & Licensure
IL State Medical License 1966 - Present
TX State Medical License 1971 - 2027
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification FirstNet (Image Results), Cerner Corporation, 2014-2017
- CMS Meaningful Use Stage 2 Certification HealtheLife and FirstNet, Cerner Corporation, 2014-2017
- CMS Meaningful Use Stage 2 Certification Powerchart (Image Results), Cerner Corporation, 2014-2017
Publications & Presentations
PubMed
- 1 citationsEvaluation of the potential of Rejuveinix plus dexamethasone against sepsis.Fatih M Uckun, Muhammad Saeed, Mustafa Awili, Ibrahim H Ozercan, Sanjive Qazi
Future Microbiology. 2022-10-01 - 21 citationsOral Sabizabulin for High-Risk, Hospitalized Adults with Covid-19: Interim Analysis.K Gary Barnette, Michael S Gordon, Domingo Rodriguez, T Gary Bird, Alan Skolnick
NEJM Evidence. 2022-09-01 - 11 citationsOpaganib in Coronavirus Disease 2019 Pneumonia: Results of a Randomized, Placebo-Controlled Phase 2a Trial.Kevin L Winthrop, Alan W Skolnick, Adnan M Rafiq, Scott H Beegle, Julian Suszanski
Open Forum Infectious Diseases. 2022-07-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
